Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley Deeks

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Communicable Diseases Intelligence Quarterly Report|April 21, 2009
Annual report: surveillance of adverse events following immunisation in Australia, 2007Glenda Lawrence, Michael S Gold, Richard Hill, et al.
Vaccine|October 14, 2008
Early experience with human papillomavirus vaccine introduction in the United States, Canada and AustraliaAbigail Shefer, Lauri Markowitz, Shelley Deeks, et al.
Human Vaccines & Immunotherapeutics|July 22, 2021
Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, CanadaWallis Rudnick, Sarah Wilson, Jo Ann Majerovich, et al.
Transfusion Medicine Reviews|January 11, 2003
Proceedings of a consensus conference: blood-borne HIV and hepatitis-optimizing the donor selection processJo Anne Chiavetta, Shelley Deeks, Mindy Goldman, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 3, 2026
Changing case definition: An analysis of its impact on Lyme disease surveillance in Nova ScotiaKelachi Nsitem, Jennifer Cram, Aini Khan, et al.
Vaccine|September 1, 2023
Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemicMatthew Tunis, Shelley Deeks, Robyn Harrison, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 15, 2003
Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000Jo Anne Chiavetta, Michael Escobar, Alice Newman, et al.
Plos One|December 17, 2011
Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysisKumanan Wilson, Steven Hawken, Jeffrey C Kwong, et al.
Vaccine|March 6, 2025
Investigating the measles susceptibility gap in Ontario infantsShelly Bolotin, James Wright, Elizabeth McLachlan, et al.
BMC Medical Research Methodology|July 14, 2010
Pan-Canadian assessment of pandemic immunization data collection: study methodologyJennifer A Pereira, Susan Quach, Christine Heidebrecht, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Communicable Diseases Intelligence Quarterly Report|April 21, 2009
Annual report: surveillance of adverse events following immunisation in Australia, 2007Glenda Lawrence, Michael S Gold, Richard Hill, et al.
Vaccine|October 14, 2008
Early experience with human papillomavirus vaccine introduction in the United States, Canada and AustraliaAbigail Shefer, Lauri Markowitz, Shelley Deeks, et al.
Human Vaccines & Immunotherapeutics|July 22, 2021
Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, CanadaWallis Rudnick, Sarah Wilson, Jo Ann Majerovich, et al.
Transfusion Medicine Reviews|January 11, 2003
Proceedings of a consensus conference: blood-borne HIV and hepatitis-optimizing the donor selection processJo Anne Chiavetta, Shelley Deeks, Mindy Goldman, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 3, 2026
Changing case definition: An analysis of its impact on Lyme disease surveillance in Nova ScotiaKelachi Nsitem, Jennifer Cram, Aini Khan, et al.
Vaccine|September 1, 2023
Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemicMatthew Tunis, Shelley Deeks, Robyn Harrison, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 15, 2003
Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000Jo Anne Chiavetta, Michael Escobar, Alice Newman, et al.
Plos One|December 17, 2011
Adverse events following 12 and 18 month vaccinations: a population-based, self-controlled case series analysisKumanan Wilson, Steven Hawken, Jeffrey C Kwong, et al.
Vaccine|March 6, 2025
Investigating the measles susceptibility gap in Ontario infantsShelly Bolotin, James Wright, Elizabeth McLachlan, et al.
BMC Medical Research Methodology|July 14, 2010
Pan-Canadian assessment of pandemic immunization data collection: study methodologyJennifer A Pereira, Susan Quach, Christine Heidebrecht, et al.
Pageof 3